21 mai 2013 - Mae Ku, Tak, Thaïlande - un garçon avec un cas grave de paludisme établit dans son lit pendant qu'il attend une transfusion de sang de sauvetage à l'Mawker SMRU thaïlandais dans la clinique Mae Ku, la Thaïlande. Les professionnels de la santé voient de plus en plus de preuve du paludisme résistant à l'artémisinine qui sortent de la jungle d'Asie du sud-est. L'artémisinine a été le premier choix pour la lutte contre le paludisme en Asie du sud-est de 20 ans. Depuis quelques années pourtant, les travailleurs de la santé au Cambodge et au Myanmar (Birmanie) voient des signes que le parasite du paludisme est devenu résistant à l'artémisinine. Les scientifiques qui étudient le paludisme

• Contributeur: ZUMA Press, Inc. / Alamy Banque D'Images
• ID de l’image: D8AB0J
• Taille du fichier: 39,3 MB (1,7 MB Téléchargement compressé)
• Autorisations: Modèle - non | Propriété - non
• Dimensions: 4279 x 3213 px | 36,2 x 27,2 cm | 14,3 x 10,7 inches | 300dpi
• Date de la prise de vue: 21 mai 2013
• Photographe: ZUMA Press

Informations supplémentaires

Cette image peut avoir des imperfections car il s’agit d’une image historique ou de reportage.

May 21, 2013 - Mae Ku, Tak, Thailand - A boy with a severe case of malaria lays in his bed while he awaits a lifesaving blood transfusion at the Mawker Thai SMRU clinic in Mae Ku, Thailand. Health professionals are seeing increasing evidence of malaria resistant to artemisinin coming out of the jungles of Southeast Asia. Artemisinin has been the first choice for battling malaria in Southeast Asia for 20 years. In recent years though, health care workers in Cambodia and Myanmar (Burma) are seeing signs that the malaria parasite is becoming resistant to artemisinin. Scientists who study malaria are concerned that history could repeat itself because chloroquine, an effective malaria treatment until the 1990s, first lost its effectiveness in Cambodia and Burma before spreading to Africa, which led to a spike in deaths there. Doctors at the Shaklo Malaria Research Unit (SMRU), which studies malaria along the Thai Burma border, are worried that artemisinin resistance is growing at a rapid pace. Dr. Aung Pyae Phyo, a Burmese physician at a SMRU clinic just a few meters from the Burmese border, said that in 2009, 90 percent of patients were cured with artemisinin, but in 2010, it dropped to about 70 percent and is now between 55 and 60 percent. He said the concern is that as it becomes more difficult to clear the parasite from a patient, progress that has been made in combating malaria will be lost and the disease could make a comeback in Southeast Asia. (Credit Image: © Jack Kurtz/ZUMAPRESS.com)